Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
Pharmacologic Augmentation of Neurocognition and Cognitive Training in Psychosis
This study has finished and is no longer accepting participants.
In San Diego
Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Pharmacologic Augmentation of Neurocognition and Cognitive Training in Psychosis
This study has finished and is no longer accepting participants.
In San DiegoA Randomized, Double-Blind, Placebo-Controlled, Comparative Study to Evaluate the Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia in Patients With Schizophrenia and Schizoaffective Disorders
This study ended early.
Multiple locations, including VictoriaSelf-regulation Strategies to Improve Exercise Behavior: A Randomized Clinical Trial in Persons With Schizophrenia Spectrum Disorders
This study has finished and is no longer accepting participants.
In ReichenauThis study has finished and is no longer accepting participants.
In Hong KongAn Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
This study has finished and is no longer accepting participants.
In Chapel HillA Phase 2a, Multiple Dose, Placebo Controlled, Randomized, Two Way Crossover Study to Assess the Efficacy of SCH 420814 in Reducing Anti Psychotic-Induced Extra Pyramidal Symptoms Among Subjects With Schizophrenia and Schizoaffective Disorders
This study ended early.
Location not clearly listedA Study on Targeted Intervention for Insight in Patients with First Episode and Clinical High Risk of Schizophrenia Based on Theta Oscillation in Anterior Cingulate Cortex
This study was withdrawn before enrollment.
In ShanghaiAN OPEN-LABEL, RANDOMIZED, THREE-PERIOD, TWO-SEQUENCE CROSSOVER, REPEATED-DOSE, REPLICATE DESIGN STUDY TO DETERMINE THE BIOEQUIVALENCE OF TWO DIFFERENT LURASIDONE FORMULATIONS IN PATIENTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE, OR SCHIZOPHRENIFORM DISORDER
This study has finished and is no longer accepting participants.
In GlendalePersonal Identity, Cognitive Factors and Psychotic Symptoms in Schizophrenia and Related Disorders: A Cross-sectional Study With the Repertory Grid Technique
This study has finished and is no longer accepting participants.
In Sant Boi de LlobregatA Phase II Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 52-week Treatment Period as an Early Intervention in Patients With Attenuated Psychosis Syndrome.
This study ended early.
Multiple locations, including Culver CityTreatment of Schizophrenia and Related Disorders in Children and Adolescents
This study has finished and is no longer accepting participants.
Multiple locations, including MedfordThis study has finished and is no longer accepting participants.
Multiple locations, including LimogesWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.